Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Chubb
Covington
Mallinckrodt
Queensland Health
McKinsey
Dow
Teva
Accenture

Generated: June 21, 2018

DrugPatentWatch Database Preview

Claims for Patent: 9,296,694

« Back to Dashboard

Summary for Patent: 9,296,694
Title:Azacyclic compounds
Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
Inventor(s): Andersson; Carl-Magnus A. (Glostrup, DK), Croston; Glenn (San Diego, CA), Hansen; Eva Louise (Glostrup, DK), Uldam; Allan Kjaersgaard (Glostrup, DK)
Assignee: ACADIA PHARMACEUTICALS INC. (San Diego, CA)
Application Number:14/628,156
Patent Claims: 1. A compound of formula (I) ##STR00010## or a pharmaceutically acceptable salt thereof, wherein Z is ##STR00011## in which R is a hydrogen, a lower alkyl group, a cyclic organyl group, or a substituted or unsubstituted aralkyl or heteroaralkyl group; and n is 1; X.sub.1 is NH or N(lower alkyl) group; X.sub.2 is methylene; Y.sub.1 is methylene; Y.sub.2 is a bond, methylene, ethylene, or vinylene; Ar.sub.1 and Ar.sub.e are phenyl groups p-substituted with a substituent selected from the group consisting of lower alkyl, lower alkoxy and halogen; and W is oxygen.

2. The compound or pharmaceutically acceptable salt of claim 1, wherein R is a lower alkyl group.

3. The compound or pharmaceutically acceptable salt of claim 2, wherein R is selected from the group consisting of methyl, ethyl, propyl, butyl, methylbutyl, cyclopropyl, cyclohexyl, iso-propyl and tert-butyl.

4. The compound or pharmaceutically acceptable salt of claim 2, wherein aR.sub.1 and Ar.sub.2 are p-substituted with different substituents.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Medtronic
Healthtrust
Queensland Health
Chubb
McKinsey
Express Scripts
Moodys
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.